[19]
Ohgiya, T.; Yamazaki, K.; Matsuda, K.; Murakami, T.; Watanabe, T.; Maejima, T. Preparation of N, 5-disubstituted pyrimidin-2-amine compounds for reducing low-density lipoprotein (LDL) cholesterol level in blood. WO 2013137371 A1, 2013.
[27]
Donello, I.E.; Yang, R.; Leblond, B.; Beausoleil, E.; Casagrande, A.S.; Desire, L.J.R.; Pando, M.P.; Chauvignac, C.; Taverne, T. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphor-diesterase 10 (PDE10A). PCT Int. Appl., 2012, 2012112946, 23.
[29]
Lin, H.; Yang, P.; Fei, T.; Liu, F. Synthesis and crystal structure of novel β-lactam derivatives bearing quinoline moiety via [2+ 2] cycloaddition. J. Heterocycl. Chem., 2016, 53(6), 2036-2041.
[35]
Bhuyan, P.J.; Devi, I.; Kalita, P.K. . Synthesis of novel pyrrolo[ 1',2':1,6] and morpholino[1',2':1,6]tetrahydropyrido[2,3-b]- quinoline. IN 2006DE00891, 2016.
[36]
Rao, P.V.; Goli, K. Microwave assisted synthesis and antibacterial activies of some (E)-1-phenyl-3-(2-thiomorpholinoquinolin-3-yl) prop-2-en-1-one using basic catalyst. Int. J. Chem. Sci., 2014, 12(4), 1577-1586. [https://www.cabdirect.org/cabdirect/abstract/
[37]
Paitandi, R.P.; Mukhopadhyay, S.; Singh, R.S.; Sharma, V.; Mobin, S.M.; Pandey, D.S. Anticancer activity of iridium (III) complexes based on a pyrazole-appended quinoline-based BODIPY. Inorg. Chem., 2017, 56(20), 12232-12247.
[39]
Nakamura, Y.; Hayashi, N.; Higashijima, T.; Kubota, H.; Oka, K. Trisubstituted amine compounds as cetp inhibitors and their preparation, pharmaceutical compositions and use in the treatment of arteriosclerotic diseases, hyperlipemia, dyslipidemia and related diseases.us; , 2009, p. 20090023729.